These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 2961751)
41. Sialylpentaosylceramide detected with anti-GM2 monoclonal antibody. Structural characterization and complementary expression with GM2 in gastric cancer and normal gastric mucosa. Dohi T; Ohta S; Hanai N; Yamaguchi K; Oshima M J Biol Chem; 1990 May; 265(14):7880-5. PubMed ID: 2139874 [TBL] [Abstract][Full Text] [Related]
42. [Isolation and characteristics of hexosaminidase A and activator protein from human kidney]. Aronovich EL; Akhunov VS; Krasnopol'skaia KD Biokhimiia; 1990 Jan; 55(1):43-51. PubMed ID: 2140519 [TBL] [Abstract][Full Text] [Related]
43. A Pro504 --> Ser substitution in the beta-subunit of beta-hexosaminidase A inhibits alpha-subunit hydrolysis of GM2 ganglioside, resulting in chronic Sandhoff disease. Hou Y; McInnes B; Hinek A; Karpati G; Mahuran D J Biol Chem; 1998 Aug; 273(33):21386-92. PubMed ID: 9694901 [TBL] [Abstract][Full Text] [Related]
44. Characterization of an alternatively spliced GM2 activator protein, GM2A protein. An activator protein which stimulates the enzymatic hydrolysis of N-acetylneuraminic acid, but not N-acetylgalactosamine, from GM2. Wu YY; Sonnino S; Li YT; Li SC J Biol Chem; 1996 May; 271(18):10611-5. PubMed ID: 8631864 [TBL] [Abstract][Full Text] [Related]
46. Interaction of GM2 activator protein with glycosphingolipids. Li SC; Hama Y; Li YT Adv Exp Med Biol; 2001; 491():351-67. PubMed ID: 14533808 [TBL] [Abstract][Full Text] [Related]
47. Biochemical characterization of the Cys138Arg substitution associated with the AB variant form of GM2 gangliosidosis: evidence that Cys138 is required for the recognition of the GM2 activator/GM2 ganglioside complex by beta-hexosaminidase A. Xie B; Rigat B; Smiljanic-Georgijev N; Deng H; Mahuran D Biochemistry; 1998 Jan; 37(3):814-21. PubMed ID: 9454570 [TBL] [Abstract][Full Text] [Related]
48. Direct determination of the substrate specificity of the alpha-active site in heterodimeric beta-hexosaminidase A. Hou Y; Tse R; Mahuran DJ Biochemistry; 1996 Apr; 35(13):3963-9. PubMed ID: 8672428 [TBL] [Abstract][Full Text] [Related]
49. GM2 gangliosidosis in a Japanese spaniel. Cummings JF; Wood PA; Walkley SU; de Lahunta A; DeForest ME Acta Neuropathol; 1985; 67(3-4):247-53. PubMed ID: 2931941 [TBL] [Abstract][Full Text] [Related]
50. Deficiency of the hexosaminidase A activator protein in a case of GM2 gangliosidosis; variant AB. Hechtman P; Gordon BA; Ng Ying Kin NM Pediatr Res; 1982 Mar; 16(3):217-22. PubMed ID: 6801612 [TBL] [Abstract][Full Text] [Related]
51. Ganglioside storage, hexosaminidase lability, and urinary oligosaccharides in adult Sandhoff's disease. Bolhuis PA; Oonk JG; Kamp PE; Ris AJ; Michalski JC; Overdijk B; Reuser AJ Neurology; 1987 Jan; 37(1):75-81. PubMed ID: 2948136 [TBL] [Abstract][Full Text] [Related]
52. Identification of plasma membrane associated mature beta-hexosaminidase A, active towards GM2 ganglioside, in human fibroblasts. Mencarelli S; Cavalieri C; Magini A; Tancini B; Basso L; Lemansky P; Hasilik A; Li YT; Chigorno V; Orlacchio A; Emiliani C; Sonnino S FEBS Lett; 2005 Oct; 579(25):5501-6. PubMed ID: 16212960 [TBL] [Abstract][Full Text] [Related]
53. Interaction of activating protein and surfactants with human liver hexosaminidase A and GM2 ganglioside. Hechtman P; Kachra Z Biochem J; 1980 Mar; 185(3):583-91. PubMed ID: 7387624 [TBL] [Abstract][Full Text] [Related]
54. Juvenile GM2 gangliosidosis (AMB variant): inability to activate hexosaminidase A by activator protein. Inui K; Grebner EE; Jackson LG; Wenger DA Am J Hum Genet; 1983 Jul; 35(4):551-64. PubMed ID: 6224417 [TBL] [Abstract][Full Text] [Related]
55. Assay of ganglioside GM2-N-acetyl-beta-D-galactosaminidase activity in human fibroblasts employing the natural activator protein--diagnosis of variant forms of GM2 gangliosidosis. Erzberger A; Conzelmann E; Sandhoff K Clin Chim Acta; 1980 Dec; 108(3):361-8. PubMed ID: 6781795 [TBL] [Abstract][Full Text] [Related]
56. Tay-Sachs disease brain cells in culture: mobilization of stored GM2 after concanavalin A-mediated uptake of hexosaminidase A. Hoffman LM; Brooks SE; Amsterdam D; Oropello J; Schneck L J Neurosci Res; 1980; 5(5):413-7. PubMed ID: 7441795 [TBL] [Abstract][Full Text] [Related]
57. Severe sensory ataxia and demyelinating polyneuropathy with IgM anti-GM2 and GalNAc-GD1A antibodies. Lopate G; Choksi R; Pestronk A Muscle Nerve; 2002 Jun; 25(6):828-36. PubMed ID: 12115971 [TBL] [Abstract][Full Text] [Related]
58. Isolation and structural characterization of N-acetyl- and N-glycolylneuraminic-acid-containing GalNAc-GD1a isomers, IV4GalNAcIV3Neu5AcII3Neu5GcGgOse4Cer and IV4GalNAcIV3Neu5GcII3Neu5AcGgOse4Cer, from bovine brain. Casellato R; Brocca P; Li SC; Li YT; Sonnino S Eur J Biochem; 1995 Dec; 234(3):786-93. PubMed ID: 8575436 [TBL] [Abstract][Full Text] [Related]
59. Identification of functional domains within the alpha and beta subunits of beta-hexosaminidase A through the expression of alpha-beta fusion proteins. Tse R; Wu YJ; Vavougios G; Hou Y; Hinek A; Mahuran DJ Biochemistry; 1996 Aug; 35(33):10894-903. PubMed ID: 8718882 [TBL] [Abstract][Full Text] [Related]
60. The specificity of human N-acetyl-beta-D-hexosaminidases towards glycosphincolipids is determined by an activator protein. Conzelmann E; Sandhoff K Adv Exp Med Biol; 1980; 125():295-306. PubMed ID: 6444774 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]